Here are the DEF 14A proxy statements from SeaStar Medical Holding Corporation Warrant (ICUCW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow ICUCW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ICUCW filings page.
SeaStar Medical Holding Corporation is asking stockholders to vote at its virtual 2026 annual meeting on four key items. Stockholders will elect one Class I director, John Neuman, to serve until the 2029 annual meeting, and vote on an expanded equity plan.
The company seeks approval to amend and restate its 2022 Equity Incentive Plan to increase authorized common shares under the plan from 207,046 to 896,546, following a 1-for-10 reverse stock split effective January 5, 2026. Stockholders will also vote on ratifying WithumSmith+Brown, PC as independent auditor for 2026 and on a possible adjournment of the meeting if more time is needed to gather votes. As of April 24, 2026, 3,997,002 shares of common stock were outstanding and entitled to one vote per share.